-

Navitus Helps Industry Prepare for Biggest Pharmacy Standard Change in Decades

New requirements will modernize all pharmacy transaction data

MADISON, Wis.--(BUSINESS WIRE)--As the pharmacy industry launches its most significant technology transition in decades, Navitus is helping clients and partners move to the new federal standard for claims and other information vital for all prescription transactions.

The switch to the National Council for Prescription Drug Programs’ new F6 standard affects every organization involved in real-time prescription transactions, including pharmacy benefit managers (PBMs) such as Navitus, pharmacies, health plans and technology vendors.

More than a routine upgrade, F6 introduces extensive changes to the data and functionality that support prescription operations. The new standard is designed to improve accuracy, flexibility and data exchanges of pharmacy transactions, while providing for evolving industry needs. Those needs include prior authorization, coordination of benefits, eligibility verification, specialty pharmacy and emerging care models, enabling health care organizations to better support timely, coordinated and affordable patient care.

With the transition set to begin August 14, 2027, and full industry compliance required by April 14, 2028, organizations across health care are upgrading their technology, operations and business systems and processes to meet the new standard.

"F6 is one of the most consequential changes in pharmacy transaction standards," said Darryl Munden, Chief Operating Officer at Navitus. "Beyond the technical conversion, organizations must understand how the new standard affects workflows, vendor integrations, testing strategies and stakeholder communications. Successful implementation will require coordination across health care."

Navitus has launched an enterprise-wide program involving experts in technology, operations, compliance, client services and industry standards. The company's industry standards team, for example, is engaged with industry organizations, discussing regulatory guidance and implementation with key stakeholders to help them understand what the new standard will mean.

The F6 transition will require extensive coordination among health plans, PBMs, pharmacies, vendors and technology partners to ensure service continuity during implementation. Key areas of focus include transaction testing, data exchange requirements, system interoperability and operational readiness.

"As organizations move from planning to execution, the industry will need practical guidance and collaboration," Munden said. "Our goal is not only to ensure readiness at Navitus but also to help clients and partners understand what changes are coming industry-wide and how they can prepare."

Navitus will continue providing updates, educational resources and implementation guidance to clients, partners and other stakeholders as the industry moves toward adoption of F6. Additional information is available at NCPDP.org.

Navitus experts involved in F6 work are also available for media interviews about this project and their experience with it.

About Navitus:
Navitus remains the nation’s first transparent, pass-through pharmacy benefit manager (PBM), serving more than 13 million lives nationwide. It uniquely brings clarity to drug pricing and removes costs from the drug supply chain. Unlike traditional PBMs that generate profit by retaining an undisclosed portion of rebates and discounts negotiated with drug manufacturers and pharmacies, Navitus passes along the complete savings to clients, enabling them to make medication more affordable for their members. The Navitus PBM was established 23 years ago by Navitus Health Solutions, LLC, a pioneering pharmacy solutions company. The organization delivers a range of services through portfolio brands including Navitus, Lumicera, Archimedes and Clarventa. Owned by SSM Health and Costco, Navitus Health Solutions serves nearly 20 million lives across 800 clients including employers, unions, government plans, payers and health systems.

Contacts

For media inquiries:
Navitus@AircoverPR.com

Navitus


Release Versions

Contacts

For media inquiries:
Navitus@AircoverPR.com

More News From Navitus

Navitus releases Drug Trend Report, “Clarity for Action”

MADISON, Wis.--(BUSINESS WIRE)--Navitus today released its 10th annual Drug Trend Report, “Clarity for Action,” the company’s flagship annual analysis of prescription drug cost trends. The report details how utilization growth and therapeutic innovation drove prescription drug costs in 2025 and outlines clear actions for health plans and plan sponsors to counter accelerating pressure. Across the Navitus commercial book of business, net prescription drug costs increased 8.4%, up from 7% in 2024,...

68% of GLP-1 Users Say Cost Influenced Their Treatment Decisions

MADISON, Wis.--(BUSINESS WIRE)--Nearly seven in 10 Americans who have taken a GLP-1 medication say the drug’s cost influenced their decision to start or continue treatment, according to a new nationwide Navitus Health Solutions Pulse Survey released today. “GLP-1 medications offer meaningful health benefits, but this survey highlights trends and concerns related to medication cost and long-term accessibility to these drugs,” said Sharon Faust, Chief Pharmacy Officer at Navitus Health Solutions,...

Navitus Achieves HITRUST r2 Certification, Reinforcing Its Commitment to Cybersecurity and Information Protection

MADISON, Wis.--(BUSINESS WIRE)--Navitus, the nation’s first and largest transparent, pass-through pharmacy benefit manager (PBM), today announced it has earned HITRUST r2 Certification for cybersecurity and information protection. This is the third consecutive time Navitus has achieved HITRUST certification, following its initial certification in 2023. HITRUST Certification provides independent validation that Navitus has implemented strong, effective controls aligned with leading cybersecurity...
Back to Newsroom